• Immunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts

    Источник: Buzz FX / 04 окт 2024 04:03:09   America/Chicago


    Immunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts Written by MarketBeat October 4, 2024 Share Link copied to clipboard. Immunic, Inc. ( NASDAQ:IMUX - Get Free Report ) has received a consensus recommendation of "Buy
    Read more...
Опубликовать